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Adenovirus minor coat protein VI contains a membrane-disrupting peptide which is inactive when 
VI is bound to hexon trimers. Protein VI must be released during entry to ensure endosome 
escape. Hexon:VI stoichiometry has been uncertain, and only fragments of VI have been 
identified in the virion structure. Recent findings suggest an unexpected relationship between VI 
and the major core protein, VII. According to the high resolution structure of the mature virion, VI 
and VII may compete for the same binding site in hexon; and non-infectious human adenovirus 
type 5 particles assembled in the absence of VII (Ad5-VII-) are deficient in proteolytic maturation 
of protein VI and endosome escape. Here we show that Ad5-VII- particles are trapped in the 
endosome because they fail to increase VI exposure during entry. This failure was not due to 
increased particle stability, because capsid disruption happened at lower thermal or mechanical 
stress in Ad5-VII- compared to wild-type (Ad5-wt) particles. Cryoelectron microscopy difference 
maps indicated that VII can occupy the same binding pocket as VI in all hexon monomers, strongly 
arguing for binding competition. In the Ad5-VII- map, density corresponding to the immature 
amino-terminal region of VI indicates that in the absence of VII the lytic peptide is trapped inside 
the hexon cavity, and clarifies the hexon:VI stoichiometry conundrum. We propose a model where 
dynamic competition between proteins VI and VII for hexon binding facilitates the complete 
maturation of VI, and is responsible for releasing the lytic protein from the hexon cavity during 
entry and stepwise uncoating. 
 
Significance Statement 
To achieve their full infectious potential, virus particles must transition from relatively inert to highly 
reactive agents upon encountering an appropriate host cell. Here we examine the basis for this 
transition in adenovirus, a human pathogen and widely used gene-transfer vector. Adenovirus 
particles contain more than 10 different proteins plus the viral genome. We focus on the interplay 
between two of these proteins: The major core protein VII, involved in genome condensation, and 
the internal minor coat protein VI, bearing lytic activity required to rupture endosomes during entry. 
Our data support a model where the ability of protein VII to compete protein VI in hexon binding 





Adenoviruses are complex non-enveloped, double-stranded DNA (dsDNA) viruses. The virion of 
human adenovirus type 5 (HAdV-C5) consists of a 95-nm diameter icosahedral pseudoT = 25 
protein shell enclosing a non-icosahedral DNA-protein core. The capsid is composed of 240 
hexon trimers, 12 pentameric penton bases associated with a fiber sitting at each vertex, and four 
minor coat proteins: Polypeptide IX (240 copies) on the outer capsid surface, and proteins IIIa (60 
copies), VI (~320 or 360 copies, depending on two different stoichiometry determinations), and 
VIII (120 copies) on the inner one (1-4). Inside the capsid, the ~36 kbp linear dsDNA genome is 
tightly packed together with ~25 MDa of protein: ~500-800 copies of polypeptide VII, ~100 to 300 
copies of polypeptide µ, and 150 copies of polypeptide V (3, 4). Because the three core proteins 
have a large proportion of positive charges, it is expected that their main role is to help screen the 
electrostatic repulsion of the confined, negatively charged genome (5). 
During maturation, the adenovirus protease (AVP) cleaves the precursor forms of minor coat 
proteins IIIa, VI, and VIII, as well as core proteins VII and µ, the terminal protein, and the 
packaging protein L1 52/55 kDa (6-8). AVP enters the viral particle bound to the DNA molecule 
(its first cofactor) and cleaves 11 residues from the C-terminus of the polypeptide VI precursor 
(pVI). The released peptide (pVIC) is AVP second cofactor, which the protease uses as a sled to 
scan along the dsDNA and reach the rest of its targets (9-11). These include, among others, a 
second cleavage site at the N-terminal region of pVI (releasing a 33 residue-long peptide, pVIN), 
and two N-terminal cleavage sites in the precursor of the major core protein, pVII, releasing 
peptides pVIIN1 (residues 1-13) and pVIIN2 (14-24) (6). 
Protein VI is located beneath the hexon shell (2, 12) and its membrane lytic activity is crucial for 
adenovirus cell entry (13-17). Immature adenovirus particles contain the precursors of all viral 
AVP substrates. They assemble and package correctly, but fail to expose the pVI lytic peptide 
(an amphipathic α-helix at the N-terminus of protein VI) during entry, become trapped in endo-
lysosomes and therefore are not infectious (18-21). This happens because immature particles 
are more stable than the mature virions (22-24), and do not respond to the cues from receptor 
movements and confinements when bound to the plasma membrane (16, 25-27). Maturation of 
the core proteins increases the internal pressure generated by electrostatic repulsion between 
the confined DNA strands (28). This pressurization seems to provide a mechanism to facilitate 
penton release upon receptor interaction, which in turn opens the way for exposure of the lytic 
peptide (22, 23).  
Two recent studies have shown unexpected connections between proteins VI and VII. In the first 
one (29), loxP sites were inserted in the human HAdV-C5 genome flanking the pVII gene (Ad5-
VII-loxP). When Ad5-VII-loxP infects cells expressing the Cre-lox recombinase, pVII is not 
expressed because the VII locus is excised from the viral genome. The first surprising result was 
that the absence of the major core protein did not hinder particle formation and genome 
encapsidation. Therefore, the DNA condensation activity of protein VII is not necessary for the 
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adenovirus genome to fit inside the capsid. The second surprise in this study was that, in the 
particles lacking protein VII (Ad5-VII-), protein VI was present in an intermediate maturation form 
(iVI), having been cleaved only at its C-terminal site, but not at the N-terminus. Additionally, 
Ostapchuk and collaborators found that the Ad5-VII- particles were not infectious due to a defect 
in entry: These particleswere unable to escape from the endosome, similarly to the fully immature 
particles produced by the thermosensitive mutant Ad2 ts1 (19, 30). 
Why full maturation of pVI is impaired in the absence of core protein VII, and why the particles 
lacking VII are trapped in the endosome, has remained unclear. The fact that pVI was processed 
at the C-terminus means that AVP was able to produce its cofactor (pVIC), become activated, and 
process the rest of its substrates, because neither full length L1 52/55 kDa nor pVIII were detected 
in Ad5-VII- particles (29). However, AVP could not cleave pVIN, which in vitro is the first site 
processed in pVI (10). The N-terminal cleavage of pVI occurs directly upstream of the region 
containing the amphipathic α-helix (residues 34-54) involved in endosome membrane disruption 
(13, 14). This cleavage may not be required for the lytic activity of the helix, because recombinant 
pVI is able to disrupt liposome membranes in vitro (13).  
The second study revealing unexpected relationships between proteins VI and VII is the most 
recent cryo-lectron microscopy (cryo-EM) analysis of the HAdV-C5 capsid structure (2). Structural 
and biochemical analyses had previously shown that the pVIN peptide is located inside a central 
cavity of the hexon trimer that opens towards the viral core, but density for pVIN was weak and 
present only in a few hexons, indicating lack of icosahedral order, or partial occupancy (12, 31, 
32). Partial occupancy is also implied by the hexon and pVI copy numbers in the virion: There are 
too many copies of pVI (~360) to have one per hexon trimer (240), but too few to have one per 
hexon monomer (720). In Dai et al. (2), an increase from 3.5 to 3.2 Å resolution provided new 
information on the molecules generating weak density inside hexons. First, at the mouth of the 
hexon cavity, residues 109 to 143 of pVI were modeled, disconnected from pVIN. Second, the 
pVIN tracing was reversed with respect to the previous structures (31, 32), in such a way that in 
the latest model (2) the pVIN cleavage site is not accessible at the rim of the hexon cavity, but 
hidden inside and oriented away from the core. This new disposition makes it more difficult to 
understand how AVP, sliding on the DNA, can reach its target sequence in pVIN (SI Appendix, 
Fig. S1). Third, it was shown that one of the densities inside the hexon cavity did not correspond 
to pVIN, but to the second N-terminal peptide cleaved from core protein VII (pVIIN2). This 
observation was also unexpected, because as a core protein, no part of VII was thought to be 
icosahedrally ordered, and there were no previous indications that pVII interacted with hexon. 
The pVIIN2 peptide occupies a position equivalent to that of pVIN, lining the hexon cavity wall. 
Residues Ser31 in pVIN and Phe22 of pVIIN2 interact with the same binding pocket in the hexon 
wall, raising the possibility that pVI and pVII may compete for hexon binding during assembly (2). 
In another report, we have analyzed how the absence of protein VII impinges on the mechanical 
properties and core organization of the HAdV-C5 particle (33). We showed that the entry defect 
of Ad5-VII- particles could not be attributed to either lack of internal pressure or excessive binding 
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of the naked DNA to the capsid shell. Here, we analyze exposure of protein VI, capsid stability 
and capsid structure in Ad5-VII-, in search of the reasons why these particles are impaired in pVI 
maturation and endosomal escape. Our results show the organization of the pVI lytic peptide 
inside the hexon cavity before pVIN cleavage, and provide the basis for a model in which 
competition between the precursors pVI and pVII for hexon binding is crucial to regulate 





Exposure of membrane lytic protein VI is impaired in the absence of core protein VII. For 
protein VI to mediate endosome disruption, the lytic peptide (amphipathic helix in residues 34-54) 
needs to be released from the interior of the viral particle (13). Therefore, we investigated whether 
lack of protein VII had an effect on exposure of protein VI upon viral entry. To this end, we 
characterized the exposure of protein VI in human A549 cells infected with atto 565-labelled viral 
particles upon cell entry. The amount of internalized particles was estimated by counting the dots 
positive for atto 565 but negative for monoclonal anti-hexon labeling in non-permeabilized cells. 
As expected (29), the Ad5-VII- virus did not present difficulties in cell internalization (SI Appendix, 
Fig. S2). The signal for protein VI obtained after cell permeabilization in HAdV-C5 wild-type (Ad5-
wt) internalized particles increased between 5 and 10 times during the first 10 min of infection, 
indicating progressive exposure of VI from the incoming particles (Fig. 1). This was consistent 
with earlier reports demonstrating exposure and complete loss of VI from the virions upon 
endosomal rupture and virion release to the cytosol (16, 34). In simultaneous experiments with 
Ad5-wt and Ad5-VII- particles (Fig. 1), we observed that the Ad5-VII- virus tended to show higher 
amounts of protein VI signal at the 0 min time point than the Ad5-wt virus, suggesting the presence 
of damaged particles in the preparations, a possibility that was supported by negative staining 
electron microscopy (EM) imaging (SI Appendix, Fig. S3). Unlike Ad5-wt, Ad5-VII- did not show 
an increase in protein VI exposure in the first 20 min of infection after warming of cold 
synchronized cells (Fig. 1B). Of four experiments (three biological replicates for one Ad5-VII- 
preparation and one test comparing in parallel four different Ad5-VII- preparations), we observed 
changes in the signal for protein VI ranging between a 2-fold decrease and a 1.5-fold increase 
during the first 10 min of infection. That is, while there was a clear increase in particle-associated 
anti-VI signal in Ad5-wt particles at 10 min in comparison to 0 min postinfection, the changes 
observed for the Ad5-VII- virus are within the experimental noise range, taking into account cell-
to-cell variability. These results indicate that Ad5-VII- particles fail to properly expose the partially 
processed polypeptide VI, in agreement with the reported failure of Ad5-VII- to penetrate the 
endosome membrane (29). 
 
Adenovirus particles lacking protein VII have reduced thermal and mechanical stability. 
The Ad5-VII- entry defect is reminiscent of that observed for particles produced by the Ad2 ts1 
mutant, which contain immature pVI and become trapped in the endocytic route (19, 30, 35). Ad2 
ts1 particles are highly stable: They can withstand harsher conditions than Ad5-wt, require more 
stress to release pentons, and therefore do not release protein VI upon entry (16, 18, 19, 22-24). 
Similarly, mutation G33A in pVI produces particles with partial processing of this protein, higher 
thermostability, lower membrane lytic activity, reduced infectivity, and more stable pentons (36, 
37). To evaluate whether increased stability could be responsible for the lack of protein VI release 
from Ad5-VII- particles, we carried out thermal and mechanical disruption assays. 
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We used extrinsic fluorescence of the DNA intercalating agent YOYO-1 to characterize capsid 
disruption as a function of temperature in Ad5-wt and A5-VII- particles. In both cases, the 
fluorescence emission of YOYO-1 increased with the temperature, as the genome became 
exposed to the solvent (Fig. 2). The half-transition temperature (T0.5) estimated for Ad5-wt was 
47.35 ± 0.06 ºC, in agreement with previous studies (13, 22, 24, 38, 39). In contrast, for Ad5-VII- 
the maximum rate of DNA exposure happened at 44.45 ± 0.10 ºC. This result indicates that Ad5-
VII- particles are thermally less stable than Ad5-wt. 
To analyze the mechanical stability of the Ad5-VII- particles, we used mechanical fatigue induced 
by atomic force microscopy (AFM). This method involves repeated imaging of the same virus 
particle using very low forces (~100 pN), far below the breaking force of the capsid. In this way, 
we simultaneously induce and monitor the gradual disassembly of single virus particles (23). 
Topography images taken at the beginning of the experiment showed no differences between 
Ad5-wt and Ad5-VII- particles (Fig. 3A, panels #1). As the experiment proceeded, mechanical 
fatigue caused the sequential removal of pentons, followed by complete particle collapse. In the 
example shown in Fig. 3A, we show that for Ad5-VII- the first penton fell off the capsid at image 
#3, and the third penton at image #9. The capsid collapsed after #18 images. In contrast, in the 
Ad5-wt the first penton falls off at image #43, and the capsid collapsed at image #59 (Fig. 3A). 
We quantified the rate of penton loss for nine Ad5-VII- and seven Ad5-wt viral particles. In Fig. 
3B, pentons are considered independent identities, and the normalized penton population for all 
studied particles is plotted along the number of images taken. At the beginning of the experiment, 
all observable pentons are present for the 16 studied particles (penton population = 1). As the 
experiment proceeds, pentons fall off and the penton population decreases until there are no 
more observable pentons. The penton release distribution follows an exponential decay for both 
types of particles. The mean lifetime of a penton is 12 images for Ad5-VII-, and 26 images for 
Ad5-wt, indicating that penton loss occurs faster in Ad5-VII- particles (Table 1). This higher 
propensity to release pentons agrees with our observations showing that lack of core protein VII 
increases the particle internal pressure (33).  
To further analyze the disassembly dynamics, we quantified the variation in particle volume during 
the mechanical fatigue assays (Fig. 3C). At the beginning of the experiment, the particle volume 
remained constant for all particles analyzed. After losing the three pentons on the upper facet, 
the volume drops at a similar rate for both kinds of particles (13% volume loss/image for Ad5-VII-
, 14% volume loss/image for Ad5-wt). A clear difference, however, was the time elapsed until the 
particle volume starts to decrease: Ad5-wt particles lost 50% of their volume after being imaged 
~50 times, while for Ad5-VII- the same decrease in volume occurred after only 15 images (Fig. 
3D). That is, Ad5-VII- particles start losing volume earlier than Ad5-wt particles, consistent with 
the penton release tendency. Therefore, penton resilience determines the stability of the virus 
particle under mechanical fatigue. 
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In conclusion, our results so far indicate that Ad5-VII- particles are less stable than Ad5-wt under 
both thermal and mechanical stress. Therefore, the defect of Ad5-VII- virions in protein VI 
exposure is unlikely due to higher mechanical or thermal stability, although it might be due to an 
inability of the VII- virions to respond to the pulling forces from CAR receptor movements and 
holding forces of the immobile integrins. 
 
Lack of density in the Ad5-VII- cryo-EM map hexon cavity confirms the interaction of core 
protein VII with hexon. In Figs. 2 and 3 we have shown that Ad5-VII- particles are damaged at 
lower stress levels than Ad5-wt upon heating (Fig. 2, accessibility of YOYO-1 to the genome) or 
repeated nanoindentation (Fig. 3, penton and particle volume loss). Also in agreement with their 
decreased stability, we show that before entering the cell, many Ad5-VII- particles were already 
damaged to such an extent as to allow antibody binding to protein VI (Fig. 1B, time point 0). The 
label for protein VI at this point could originate from molecules still attached to capsid fragments, 
or just in the near proximity. However, there is no increase in the label for protein VI in the first 30 
min postentry, a behavior very different from that of Ad5-wt (Fig. 1B). All these results combined 
indicate that, even if Ad5-VII- particles are more prone than Ad5-wt to lose their structural integrity, 
in the cell they are unable to release enough copies of the lytic peptide to cause endosome 
escape. To try to understand why, we investigated the structural differences between Ad5-VII- 
and Ad5- wt particles using cryo-EM (SI Appendix, Fig. S4). A difference map was calculated by 
subtracting the Ad5-VII- map from Ad5- wt, to show density corresponding to elements present in 
the mature virion but absent when the major core protein is missing. This map (Fig. 4A, red 
density) showed small differences located in the interior of the capsid, near the rim of the hexon 
cavity (red circles, Fig. 4A). When we overlap the most recent Ad5-wt structure [PDB ID code 
6B1T (2)] with our maps, we observe that one of the small densities absent in Ad5-VII- perfectly 
matches the position of peptide VIIN2 traced by Dai et al. (2) inside the cavity of hexon 2 in the 
asymmetric unit (AU) (Fig. 4 B and C). 
When the difference map is contoured at 1.5σ, we observe five red densities in the AU, one inside 
each of hexon trimers 1, 2 and 3, and two inside hexon 4. These difference densities occupy 
positions near the VIN/VIIN2 binding pocket in hexon, according to Dai et al. (2). Since there are 
~360 copies of pVI (3, 4) and 720 hexon monomers (organized in 240 trimers) in the capsid, at 
least half the possible binding pockets (6 out of 12 per AU) would be available for pVII to bind, in 
good agreement with the observation of 5 empty pockets when VII is not present (Fig. 4A). 
However, all difference densities are weaker than the density corresponding to hexon (3σ), 
indicating disorder or partial occupancy. At lower contour level (1σ), eight red densities located 
near the VIN/VIIN2 binding pocket in hexon can be observed in the difference map AU (SI 
Appendix, Fig. S5). One of these, located in the peripentonal hexon (hexon 1) cavity, covers the 
space occupied by one of the pVIN peptides traced in the Ad5-wt structure. One more difference 
blob per AU appears at nearly noise level (0.8σ) (SI Appendix, Fig. S5).  
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Given that protein VII is the only component missing from the Ad5-VII- particle (29), we interpret 
the (Ad5-wt minus Ad5-VII-) difference densities as an indication of binding sites left empty by the 
absence of the major core protein. This result supports the location of part of protein VII (the pVIIN2 
peptide) proposed by the latest cryo-EM study on Ad5-wt (2). The fact that more difference blobs 
appear in equivalent capsid positions at lower contour thresholds is consistent with variable 
occupancy of the pVIN/pVIIN2 binding pockets across the different hexon monomers icosahedrally 
averaged in the cryo-EM map. This result indicates that in the complete virion, the pVIIN2 peptide 
has the potential to bind all hexon monomers in the capsid, but succeeds only in part of them, 
while in the rest the binding pocket is occupied by pVIN. That is, our observations are consistent 
with the hypothesis that during Ad5 assembly, pVI and pVII compete for the same binding site in 
the hexon trimer cavity. 
 
Observation of partially processed protein VI in the Ad5-VII- particle. The inverse difference 
map showed the density corresponding to icosahedrally ordered elements present in Ad5-VII- but 
absent in Ad5-wt. Direct observation of the cryo-EM maps already revealed a clear density filling 
the inner cavity of hexons in Ad5-VII- but absent in Ad5-wt (SI Appendix, Fig. S4, white circle). 
This extra density is present in all hexons in the AU (Fig. 5 and SI Appendix, Fig. S6), and is 
consistent with an increase in order for unprocessed polypeptide VI, as shown previously for the 
immature particle (Ad2 ts1) (24, 40). Even when contoured at low density (0.8σ (Fig. 5), the 
negative difference does not cover the pVI fragments traced in the latest Ad5-wt model (neither 
pVIN nor the central VI fragment), indicating that these regions are mostly organized in the same 
way in both Ad5-wt and Ad5-VII-. 
When, instead of calculating the difference map between the two cryo-EM maps, we subtract only 
the hexon density (generated from the high resolution structure) from the Ad5-VII- map, the 
conformation of the extra density inside the hexon cavity can be analyzed in more detail. In hexon 
2, this density forms two well defined, L-shaped tubular regions directly connected to the C-
terminal residue of the pVIN peptides traced by Dai et al. (2) (Fig. 6A). Secondary structure 
predictions and circular dichroism analyses indicate that the N-terminal region of protein VI after 
cleavage by AVP is predominantly α-helical (SI Appendix, Fig. S7) (14). One of these helices 
would harbor the amphipathic, lytic peptide (Ala34-Tyr54) (13). Indeed, two α-helices, 11- and 18-
residues long, respectively, can be modeled in each of the two L-shaped densities inside the 
hexon cavity (Fig. 6B). Together with the continuity with the pVIN peptides traced in the high-
resolution structure, the shape and size of the difference density indicate that each one of the two 
L-shaped tubes corresponds to ~30 residues of protein VI, still uncleaved from the pVIN peptide. 
From the last residue in these helices (approximately residue 65), a ~50-residue-long disordered 
region would connect with the central fragment of the protein traced in Dai et al. (2), which starts 
at residue 109 (Fig 6C). Although at a limited resolution which precludes identification of side 




At the same contouring threshold, we also observed two L-shaped tubular densities inside the 
hexon 3 cavity, while in hexons 1 and 4 the density for the second tube was weaker (SI Appendix, 
Fig. S8). These results contribute to explain the long standing puzzle of the stoichiometry of 
polypeptide VI. Given the available space, it seems very difficult to fit one copy of VI per hexon 
monomer inside the trimer cavity. Hexons 2 and 3 seem to have a preference for accommodating 
two copies of VI, while in hexons 1 and 4, although two copies can be held inside the cavity, there 
is a greater probability of finding only one. The sum of 2+2+1+1 copies of VI will result in the 
previously estimated number of 6 copies per AU. Interestingly, hexons 1 and 4 differ from hexons 
2 and 3 in their interactions with another minor coat protein, polypeptide VIII (1), suggesting that 
the presence of this minor coat protein plays a role in determining the hexon:VI stoichiometry. 
Our interpretation of the densities in the hexon cavity is also consistent with the observation of 
dimeric species when a cysteine was introduced at position 48 in pVI (G48C) (41). In our model, 
the region where residue 48 would be located corresponds to the elbow of the L-shaped density 
tubes, placing the two cysteines (one from each pVI molecule) close enough for a disulfide bond 
to form (Fig. 6D). Dimers of protein VI were also detected by crosslinking assays on disrupted 
virions and extracted cores (42) 
It has previously been shown that immature pVI has lytic activity, but binding to hexon shields this 
activity (36). The mature form of VI binds to the hexon cavity more weakly than the intermediate 
one (iVI), as indicated by assays where heating of Ad5 particles carrying the pVI G33A mutation 
caused release of mature protein VI, but not of iVI (36). Our difference mapping is in agreement 
with these observations: When core protein VII is not present and the N-terminal cleavage of VI 
does not occur, the lytic peptide remains shielded by hexon, even if capsid disassembly 
proceeded unimpeded. Alternatively, it is  possible that the capsid of Ad5-VII- particles does not 
disassemble in cells, which would be supported by the observation that the incoming viral DNA 





When Ad5 protein VII is not present during assembly, pVIN is not cleaved, and the viral particle 
remains trapped in the endosome (29). The endosome escape defect is unlikely due to the 
inability of pVIN to lyse membranes, as shown by in vitro experiments with recombinant pVI (13). 
Rather, what happens is that in Ad5-VII- particles, protein VI is not released in the endosome 
(Fig. 1), preventing the interaction between its amphipathic helix and the endosome membrane. 
The inability to release protein VI is not due to increased physical stability of the Ad5-VII- particles 
(Fig. 2 and 3). Rather, the lytic peptide remains fused to the pVIN peptide, and is hidden within 
the hexon cavity, unavailable to interact with the endosome membrane (Fig. 6). 
One intriguing question is prominent in the analysis of the Ad5-VII- particles: why is pVIN not 
cleaved when protein VII is absent? Indeed, it is not clear yet how pVIN is cleaved during assembly 
in Ad5-wt, because the highest resolution structure reported so far indicates that the pVIN peptide 
is oriented with its cleavage site hidden inside the hexon cavity, away from the reach of the DNA-
bound AVP (SI Appendix, Fig. S1) (2). Our observations provide new clues to answer these 
questions, prompting a new model for the role of protein VII in regulating capsid maturation. 
Dai et al. (2) interpreted part of the density inside the cavity of one of the hexons in the AU as a 
peptide cleaved not from pVI, but from pVII, suggesting that the two proteins could compete for 
the same binding site in hexon during assembly (2). Our cryo-EM difference maps indicate that 
pVIIN2 has the ability to bind to the same pocket as pVIN in all 12 hexon monomers in the AU. In 
one viral particle, there are 500-800 copies of pVII, and 360 copies of pVI (3, 4). That is, there are 
860-1160 candidates to bind to 720 sites in the hexon trimer cavities. We propose that, due to 
this excess, proteins VI and VII establish a dynamic competition for hexon binding sites during 
assembly. As a result of this competition, pVI or pVII molecules carrying their hexon-binding N-
terminal peptides would continually be pushed out from the hexon cavity by their competitors, 
putting them in the path of AVP sliding on the DNA (Fig. 7). In the absence of protein VII, the 
competition does not exist: there are enough sites to bind for all pVI copies, and nothing to push 
the lytic peptide out from the hexon cavity. Thereby, the pVIN cleavage site would be hidden away 
from the protease. Consequently, 1) pVIN is not cleaved, and 2) the lytic peptide remains shielded 
by hexon, preventing virion escape from the endosome. 
The competition model we propose here is derived from the results presented, interpreted on the 
light of previous knowledge reported by different groups. Further experimental work, such as in 
vitro competition assays between pVI and pVII for hexon binding, or higher-resolution structural 
analyses, could in the future corroborate or refute it. Nevertheless, this model may help explain 
previous observations on the effect of pVI mutations in adenovirus maturation and infectivity. In 
mutant G33A, pVIN is not properly cleaved either, but the virion retains a considerable infectious 
potential (25%) (36). This infectivity can be caused by the presence of 50% properly cleaved VI 
copies, but our competition model highlights another difference between G33A and Ad5-VII- 
particles. In G33A, although pVIN is partially uncleaved, the competition with protein VII is present, 
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which could cause the lytic region to be bumped out of the hexon cavity and available for 
endosome membrane disruption. It has also been observed that in pVI-S28C mutant capsids, pVI 
was correctly processed at both ends, but a considerable proportion of protein VII remained 
uncleaved (37). It is possible that the change in a region close to Ser31 in pVI (the residue filling 
the common pVI/pVII binding pocket in hexon) decreases its affinity for hexon sites in such a way 
that binding of the more abundant pVII would predominate, with its subsequent protection from 
the protease. The presence of uncleaved pVII bound to the hexon cavities would result in 
enhanced bridging between shell and genome, possibly causing the observed stiffening of the 
S28C particles. In agreement with the correct maturation of pVI, in this mutant infectivity was 
slightly (twofold) higher than in the parental virus, indicating that exposure of protein VI during 
entry was unaltered, or even slightly enhanced. 
In the immature particles produced by Ad2 ts1, both pVII and pVI are present in their appropriate 
copy numbers. Therefore, it would be expected that part of the pVI molecules are forced out from 
the hexon cavity by competition with pVII. Although they would be uncleaved due to the mutation 
in AVP, in principle these molecules could be exposed and disrupt the endosome membrane. 
However, the defect in VI exposure in Ad2 ts1 seems to be related to the lower internal pressure 
exerted by the genome when condensed by the precursor versions of core proteins VII and µ, 




Materials and Methods 
Virus specimens. The Ad5-wt virus used in cryo-EM, AFM and extrinsic fluorescence assays 
was the E1-E3 deleted, GFP expressing Ad5/attP vector which is structurally wild-type (44). The 
parent virus Ad5-VII- contains loxP sites flanking the protein VII ORF  and was generated and 
propagated as described (29). Ad5-VII- particles used in entry assays were produced using A549 
cells expressing a Cre recombinase, isolated and labeled with atto 565 as previously described 
(8, 19, 45). More information can be found in SI Appendix. 
 
Endocytosis and protein VI exposure assays. Ad5-wt and Ad5-VII- particles labeled with atto 
565 were added to cells at 4 °C for 60 min. Unbound virus particles were removed, cells were 
washed once with cold medium and incubated in a 37 °C water bath for 0, 10 or 20 min. 
Afterwards, intact cells were incubated with mouse 9C12 anti-hexon antibody at 4 ºC to tag 
particles at the plasma membrane. Cells were then fixed with 3% paraformaldehyde in PBS and 
stained with affinity-purified rabbit anti-VI antibodies (16), Alexa Fluor 680-conjugated anti-mouse 
and Alexa Fluor 488-conjugated anti-rabbit antibodies (Thermo Fisher Scientific) and DAPI as 
previously described (21). Imaging was performed with a Leica SP5 confocal microscope as 
previously described (21). More information can be found in SI Appendix. 
 
Thermal stability assays. Fluorescence emission spectra from virus samples mixed with YOYO-
1 were obtained every 2 ºC along a temperature range from 20 to 70 ºC in a Horiba FluoroLog 
spectrophotometer. The dye was excited at 490 nm and maximal emission intensity was achieved 
at 509 nm. More information can be found in SI Appendix. 
 
Mechanical stability assays. For AFM imaging, virus samples were diluted in a solution of NiCl2 
in HBS to obtain a final solution of 5 mM of NiCl2 and virus concentrations of 1.5–2x1011 viral 
particles per milliliter. A drop of 20 µL of virus solution was deposited on freshly cleaved mica and 
incubated for 30 min at 4ºC before washing with 5 mM NiCl2 in HBS. The AFM (Nanotec 
Electrónica) was operated in jumping mode in liquid with the modifications described in ref. 46, 
using RC800PSA (Olympus) cantilevers with nominal spring constants of 0.05 N/m. Monitoring 
virus disassembly in real time was accomplished by repeatedly imaging each particle as 
described (23). More information can be found in SI Appendix. 
 
Cryo-EM analyses. Methods to obtain the maps used in this work have been described 
elsewhere (33). To analyze capsid differences between Ad5-wt and Ad5-VII- particles, difference 
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maps were calculated after filtering both maps at the same resolution (5.5 Å) using Xmipp and 
normalizing with UCSF Chimera. To delineate the extra density within the hexon cavities in Ad5-
VII-, density maps at 5.5 Å resolution for each hexon trimer in the AU were created from the high 
resolution model (PDB ID = 6B1T) and subtracted from the Ad5-VII- map. More information can 
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Figure 1. Reduced protein VI exposure in Ad5-VII- particles during entry in comparison to Ad5-
wt. Atto 565-labeled virus particles were added to A549 cells at 4 °C for 60 min. Unbound particles 
were washed away, and cells were shifted to 37 °C for the indicated times. Intact cells were then 
incubated with mouse 9C12 antihexon antibody at 4 °C to tag plasma membrane-associated 
viruses, and after fixation, cells were permeabilized and stained with rabbit antiprotein VI antibody. 
These primary antibodies were detected with Alexa Fluor 680-conjugated anti-mouse and Alexa 
Fluor 488-conjugated anti-rabbit antibodies. Nuclei were stained with DAPI, and samples were 
imaged by confocal microscopy. (A) Representative images shown for Ad5-wt (Upper rows) and 
Ad5-VII- (Lower rows) at the 0-min and 10-min time points are maximum projections of confocal 
stacks. (Scale bars, 10 μm.) (B) The scatter plots show per cell mean protein VI signal on 
endocytosed particles (i.e., particles devoid of 9C12 antibody signal) for 10-min and 20-min time 
points, but the 0-min time point includes all cell-associated particles. One dot represents one cell 






Figure 2. Thermal stability of adenovirus particles with or without protein VII. Extrinsic 
fluorescence measurements showing DNA exposure to solvent upon temperature increase for 
Ad5-VII- (blue) and Ad5-wt (red). Average values and error bars corresponding to the SD of four 
(Ad5-VII-) and six (Ad5-wt) experiments are plotted. Dotted lines correspond to the fit according 






Figure 3. Mechanical stability of adenovirus particles with or without protein VII. (A) 
Representative AFM images along fatigue experiments for Ad5-VIIand Ad5-wt particles adsorbed 
on mica. Release of the first, second, and third pentons from the top facet are indicated with white 
circles. (B) Analysis of penton release for 9 Ad5-VII- and 7 Ad5-wt viral particles. At the beginning 
of the experiment, all visible pentons in the images are occupied (penton population = 1). The 
penton population decreases along the experiment. (C) Comparison of the evolution of Ad5-VII- 
and Ad5-wt particle volume during the fatigue experiment. (D) The image number at which each 




Figure 4. Cryo-EM difference map showing density present in Ad5-wt but absent in Ad5-VII- 
particles. (A) The four hexon trimers in the AU (see Inset) as seen from inside the viral particle 
are shown as a gray surface generated from the high resolution HAdV-C5 structure (PDB ID code 
6B1T). The difference map obtained by subtracting the two cryo-EM maps (Ad5-wt minus Ad5-
VII-) is shown as a semitransparent red surface contoured at 1.5 σ level. Cyan, green, and yellow 
ribbons correspond to the pVI and pVII fragments traced in Dai et al. (2), as indicated in the 
schematics in C. The solid line red circle indicates the location of the pVIIN2 peptide (yellow 
ribbon, covered by the semitransparent difference map) traced by Dai et al. The dashed red 
circles indicate the position of four additional difference densities located at positions in the hexon 
cavity where either pVIN or pVIIN2 would bind, according to Dai et al. To remove visual clutter, 
only the 150 largest difference patches within a radius of 15 Å around the four hexon trimers are 
shown (UCSF Chimera sop zone # selected 15 maxComponents 150). (Inset) A schematic of the 
icosahedral asymmetric unit as seen from inside the particle, with the four hexon trimers 
numbered 1 to 4, and the positions of the two-, three-, and fivefold icosahedral symmetry axes 
depicted by a red oval, triangle, and pentagon, respectively. (B) Cutout view of hexon 2 showing 
that the difference density clearly fits with the position of pVIIN2 modeled by Dai et al. (2). (C) 
Schematic representation of proteins pVI and pVII. Numbers at the right-hand side indicate the 
length of each protein (in amino acids). Arrows point to the AVP cleavage sites. Colored boxes 
represent the fragments solved by Dai et al.  
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Figure 5. Cryo-EM difference map showing density present in Ad5-VII- but absent in Ad5-wt 
particles. (A) The four hexon trimers in the AU (see Inset) as seen from inside the viral particle 
are shown as a gray surface generated from the HAdV-C5 high-resolution structure (PDB ID code 
6B1T). The difference map obtained by subtracting the two cryo-EM maps (Ad5-VII- minus Ad5-
wt) is shown as a blue surface and contoured at 0.8 σ level. Cyan, green, and yellow ribbons 
correspond to the pVI and pVII fragments traced by Dai et al. (2), as in Fig. 4. To remove visual 
clutter, only the 80 largest difference patches within a radius of 15 Å around the four hexon trimers 
are shown (UCSF Chimera sop zone # selected 15 maxComponents 80). (B) Zoom-in on a cut-
out view of the hexon 2 trimer showing that even at this low contouring threshold the difference 







Figure 6.  Ordered density inside the hexon cavity in Ad5-VII-. (A) A difference map obtained by 
subtracting the hexon 2 density (calculated at 5.5 Å resolution from PDB ID code 6B1T) from the 
Ad5-VII- cryo-EM map, and contoured at 1.7 σ, is shown as a gray mesh. Hexon 2 (pink) and two 
copies of the pVIN peptide (cyan) as traced in PDB 6B1T are represented as ribbons. The zoom 
at the right-hand side shows the continuity between the difference density and the pVIN peptides 
traced by Dai et al. (2) (red arrows). (B) As in A, with two α-helices (11- and 18-residue long, 
respectively) modeled in each L-shaped tubular density inside the hexon cavity (purple). For a 
cleaner view, only a region of the difference map contained within 12 Å from the modeled helices 
is shown. (C) Model for the organization of one pVI monomer in the virion. The pVIN peptide 
traced by Dai et al. (cyan) is followed by the two α-helices modeled in the Ad5-VIImap (purple). A 
dotted line indicates the connection between helices, and the dashed line indicates a disordered 
region connecting the end of the modeled helices to the central region of pVI as traced by Dai et 
al. The length of each helix and of the disordered segment is indicated (in amino acids). Residue 
numbers in black correspond to the limits of the pVI regions traced by Dai et al. (2). (D) Model for 
the pVI dimer showing how our model places residue 48 of the two monomers in the hexon cavity 
in close proximity. (E) Schematic representation of polypeptide pVI as in Fig. 4C, with the position 
of the pVI lytic peptide indicated as a purple box.   
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Figure 7. Model for dynamic competition between polypeptides VI and VII. During Ad5-wt 
assembly, the N-terminal regions of pVI and pVII (keys) compete for the same binding pocket in 
the hexon monomer (lock). This competition forces one of the two binding candidates out of the 
hexon cavity, making its N-terminal cleavage site accessible to AVP (scissors), and in the case 
of protein VI, for exposure and membrane disruption in the endosome. In Ad5-VII-, pVI has no 
competitors, and therefore its N-terminal region remains bound to and hidden inside the hexon 













Table 1. Exponential decay distribution of penton release.  
Specimen Penton release 
constant  (images-1) 
Mean penton lifetime 
1/ (images) 
N 
Ad5-VII- 0.08 12 9 
Ad5-wt 0.04 26 7 
The penton distribution data follow an exponential decay function N(t)=N0e-t, where t is the 
number of images taken, and parameters such as the penton release rate constant () and mean 
life-time of a penton (1/) can be determined. The mean penton lifetime is given as number of 
images; the penton release rate constant represents the probability to release one penton in one 
image. 
 
 
